Ensign Peak Advisors
ARNA

Ensign Peak Advisors’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Ensign Peak Advisors’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-27,270
Closed -$2.1M – 1905
2020
Q4 		$2.1M Hold
27,270
– – ﹤0.01% 1042
2020
Q3 		$2.04M Buy
27,270
+17,270
+173% +$1.15M 0.01% 962
2020
Q2 		$630K Buy
+10,000
New +$550K ﹤0.01% 1413

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Ensign Peak Advisors's ARNA Position: Q1 2021 in Review

Ensign Peak Advisors sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2021, closing a stake of 27,270 shares — an estimated $2.1M sold.

Ensign Peak Advisors first reported a position in ARNA in Q2 2020 and held it in 3 quarters. The position peaked at $2.1M in Q4 2020. 235 funds tracked by Wall St. Rank hold ARNA as of Q1 2021.

  • Ensign Peak Advisors reported no remaining Arena Pharmaceuticals Inc position as of Q1 2021 after selling out during the quarter.
  • Ensign Peak Advisors sold 27,270 Arena Pharmaceuticals Inc shares in Q1 2021, an estimated $2.1M.
  • Ensign Peak Advisors first reported a position in Arena Pharmaceuticals Inc in Q2 2020 and held it in 3 quarters.
  • Ensign Peak Advisors's Arena Pharmaceuticals Inc position peaked at $2.1M in Q4 2020.
  • 235 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2021.

Based on Ensign Peak Advisors's 13F filing for Q1 2021, filed 12 May 2021.